LNTH:NASDAQ
Lantheus Holdings Inc
$99.96
arrow_upward
+0.31%(+0.31) 1D
$99.96
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LNTH...
Open
$99.78
High
$100.07
Low
$99.70
Mkt. cap
6.53B
Avg. vol.
1.08M
Volume
714.68K
P/E ratio
24.18
52-wk high
$111.86
52-wk low
$49.67
EPS
$4.13
Beta
-0.06
Shares outstanding
65.30M
No. of employees
1K
Open
$99.78
High
$100.07
Low
$99.70
Mkt. cap
6.53B
Avg. vol.
1.08M
Volume
714.68K
P/E ratio
24.18
52-wk high
$111.86
52-wk low
$49.67
EPS
$4.13
Beta
-0.06
Shares outstanding
65.30M
No. of employees
1K
News stories
From web sources and news partners
AD HOC NEWS
·
13 hours ago
Lantheus Holdings stock faces an October 14 merger vote
TipRanks
·
2 days ago
Lantheus Issues Supplemental Disclosures Ahead Curium Merger Vote
Profile
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
About Lantheus Holdings Inc
CEO-
Employees1.19K
Founded1956
HeadquartersNorth Billerica, Massachusetts, United States
SectorMedical device
Websitelantheus.com